{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:27:41Z","timestamp":1771190861450,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":2937,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1074\/jbc.m112.387316","type":"journal-article","created":{"date-parts":[[2012,7,22]],"date-time":"2012-07-22T00:13:10Z","timestamp":1342915990000},"page":"31766-31782","source":"Crossref","is-referenced-by-count":29,"title":["Euglycemic Agent-mediated Hypothalamic Transcriptomic Manipulation in the N171\u201382Q Model of Huntington Disease Is Related to Their Physiological Efficacy"],"prefix":"10.1016","volume":"287","author":[{"given":"Bronwen","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-na","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Pantaleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin M.","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin J.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin G.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"William H.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga D.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Maudsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M112.387316_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1074\/jbc.M112.387316_bib2","first-page":"237","article-title":"Therapeutic perspectives for the treatment of Huntington disease. Treating the whole body","volume":"23","author":"Martin","year":"2008","journal-title":"Histol. Histopathol."},{"key":"10.1074\/jbc.M112.387316_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington disease","volume":"24","author":"Peters\u00e9n","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1074\/jbc.M112.387316_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.2007.18.3-4.223","article-title":"Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington disease. Clinical consequences and therapeutic implications","volume":"18","author":"Aziz","year":"2007","journal-title":"Rev. Neurosci."},{"key":"10.1074\/jbc.M112.387316_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ajcn\/81.6.1335","article-title":"Energy balance in early-stage Huntington disease","volume":"81","author":"Gaba","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1074\/jbc.M112.387316_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington disease","volume":"29","author":"Van der Burg","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M112.387316_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"10.1074\/jbc.M112.387316_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin. Potential role in altered body weight in Huntington disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1074\/jbc.M112.387316_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.1074\/jbc.M112.387316_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington disease","volume":"25","author":"Morton","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M112.387316_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington disease","volume":"14","author":"Peters\u00e9n","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M112.387316_bib12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/1389450111007011237","article-title":"Hypothalamic and neuroendocrine changes in Huntington disease","volume":"11","author":"Hult","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1074\/jbc.M112.387316_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"Bj\u00f6rkqvist","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M112.387316_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","article-title":"Formation of polyglutamine inclusions in non-CNS tissue","volume":"8","author":"Sathasivam","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M112.387316_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington disease. Relations to severity of illness and dementia","volume":"57","author":"Markianos","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1074\/jbc.M112.387316_bib16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","article-title":"Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington disease","volume":"22","author":"Papalexi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1074\/jbc.M112.387316_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.110.166470","article-title":"Transferrin fusion technology. A novel approach to prolonging biological half-life of insulinotropic peptides","volume":"334","author":"Kim","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M112.387316_bib18","doi-asserted-by":"crossref","first-page":"e14352","DOI":"10.1371\/journal.pone.0014352","article-title":"Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses","volume":"5","author":"Chadwick","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M112.387316_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately down-regulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M112.387316_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1074\/jbc.M112.387316_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/db05-0996","article-title":"Exendin-4 potently decreases ghrelin levels in fasting rats","volume":"56","author":"P\u00e9rez-Tilve","year":"2007","journal-title":"Diabetes"},{"key":"10.1074\/jbc.M112.387316_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1507\/endocrj.K06-021","article-title":"Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects","volume":"54","author":"Altinova","year":"2007","journal-title":"Endocr. J."},{"key":"10.1074\/jbc.M112.387316_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrd2826","article-title":"A network view of disease and compound screening","volume":"8","author":"Schadt","year":"2009","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1074\/jbc.M112.387316_bib24","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1074\/jbc.M804545200","article-title":"Growth factor signals in neural cells. Coherent patterns of interaction control multiple levels of molecular and phenotypic responses","volume":"284","author":"Martin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M112.387316_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(98)00730-6","article-title":"Brain vasopressin levels in Down syndrome and Alzheimer disease","volume":"806","author":"Labudova","year":"1998","journal-title":"Brain Res."},{"key":"10.1074\/jbc.M112.387316_bib26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.36.8.1133","article-title":"CSF vasopressin concentration is reduced in Alzheimer disease","volume":"36","author":"Mazurek","year":"1986","journal-title":"Neurology"},{"key":"10.1074\/jbc.M112.387316_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2007.06.058","article-title":"\u03b2-Amyloid toxicity and reversal in embryonic rat septal neurons","volume":"423","author":"Jarvis","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.M112.387316_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ajmg.b.30633","article-title":"Haplotype analysis of the IGF1-INS-TH gene cluster in Parkinson disease","volume":"147","author":"Sutherland","year":"2008","journal-title":"Am. J. Med. Genet. B"},{"key":"10.1074\/jbc.M112.387316_bib29","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.387316_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2009.02.008","article-title":"Reduced CSF CART in dementia with Lewy bodies","volume":"453","author":"Schultz","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.M112.387316_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(96)00080-7","article-title":"Somatostatin 1\u201312 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington disease patients","volume":"728","author":"Timmers","year":"1996","journal-title":"Brain Res."},{"key":"10.1074\/jbc.M112.387316_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00207450701593103","article-title":"HD phenocopies. Possible role of Saitohin gene","volume":"118","author":"Jankovi\u00e7","year":"2008","journal-title":"Int. J. Neurosci."},{"key":"10.1074\/jbc.M112.387316_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-005-0329-x","article-title":"Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson disease","volume":"113","author":"Gossrau","year":"2006","journal-title":"J. Neural. Transm."},{"key":"10.1074\/jbc.M112.387316_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.nmd.2005.06.007","article-title":"Absence of mutations in the prion-protein gene in a large cohort of HMSN patients","volume":"15","author":"Koop","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1074\/jbc.M112.387316_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/84859","article-title":"Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice","volume":"27","author":"LaVaute","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M112.387316_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng709","article-title":"Mutations in the gene encoding \u03f5-sarcoglycan cause myoclonus-dystonia syndrome","volume":"29","author":"Zimprich","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M112.387316_bib37","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1681\/ASN.2006101164","article-title":"High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis. Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations","volume":"18","author":"Tory","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M112.387316_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/B978-0-12-381328-2.00016-X","article-title":"Experimental models of HD and reflection on therapeutic strategies","volume":"98","author":"Kim","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1074\/jbc.M112.387316_bib39","doi-asserted-by":"crossref","first-page":"29457","DOI":"10.1074\/jbc.M110.131367","article-title":"Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA repair","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M112.387316_bib40","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1074\/mcp.M700478-MCP200","article-title":"The identification of potential factors associated with the development of type 2 diabetes. A quantitative proteomics approach","volume":"7","author":"Lu","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/jbc.M112.387316_bib41","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1074\/jbc.M109.073197","article-title":"Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M112.387316_bib42","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.peptides.2007.10.006","article-title":"From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides","volume":"28","author":"Pan","year":"2007","journal-title":"Peptides"},{"key":"10.1074\/jbc.M112.387316_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1152\/physiolgenomics.00042.2010","article-title":"Sex-specific genetic dissection of diabetes in a rodent model identifies Ica1 and Ndufa4 as major candidate genes","volume":"42","author":"Barkalifa","year":"2010","journal-title":"Physiol. Genomics"},{"key":"10.1074\/jbc.M112.387316_bib44","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.neuro.2009.04.011","article-title":"Subchronic exposure to arsenic decreased Sdha expression in the brain of mice","volume":"30","author":"Hong","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1074\/jbc.M112.387316_bib45","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/jnr.21304","article-title":"Increases in expression of 14-3-3\u03b7 and 14-3-3\u03b6 transcripts during neuroprotection induced by \u03949-tetrahydrocannabinol in AF5 cells","volume":"85","author":"Chen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1074\/jbc.M112.387316_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ng.380","article-title":"Mutations in the \u03b2-tubulin gene TUBB2B result in asymmetrical polymicrogyria","volume":"41","author":"Jaglin","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M112.387316_bib47","doi-asserted-by":"crossref","first-page":"E1067","DOI":"10.1152\/ajpendo.00212.2009","article-title":"Overexpression of the nuclear factor-\u03baB subunit c-Rel protects against human islet cell death in vitro","volume":"297","author":"Mokhtari","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1074\/jbc.M112.387316_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/537639","article-title":"Brain activation by peptide Pro-Leu-Gly-NH2 (MIF-1)","volume":"2010","author":"Khan","year":"2010","journal-title":"Int. J. Pept."},{"key":"10.1074\/jbc.M112.387316_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.febslet.2010.11.059","article-title":"Brainstem Hap1-Ahi1 is involved in insulin-mediated feeding control","volume":"585","author":"Niu","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.M112.387316_bib50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/gepi.20580","article-title":"Meta-analysis of heterogeneous data sources for genome-scale identification of risk genes in complex phenotypes","volume":"35","author":"Pers","year":"2011","journal-title":"Genet. Epidemiol."},{"key":"10.1074\/jbc.M112.387316_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187152506775268758","article-title":"Imidazoline receptors, novel agents, and therapeutic potential","volume":"4","author":"Head","year":"2006","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1074\/jbc.M112.387316_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2010.10.065","article-title":"Mesenchymal stem cells support dorsal root ganglion neurons survival by inhibiting the metalloproteinase pathway","volume":"172","author":"Scuteri","year":"2011","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.M112.387316_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrendo.2010.18","article-title":"SPARC. A key player in the pathologies associated with obesity and diabetes","volume":"6","author":"Kos","year":"2010","journal-title":"Rev. Endocrinol."},{"key":"10.1074\/jbc.M112.387316_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.M112.387316_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcn.2011.10.007","article-title":"Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington disease","volume":"49","author":"Hickey","year":"2012","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820629830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820629830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M112.387316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:52:57Z","timestamp":1624074777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820629830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":55,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0021925820629830"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m112.387316","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}